ALLERGY DIAGNOSTIC AND TREATMENT MARKET ANALYSIS

Market News

Key Developments

• Increasing R&D in allergies and their treatment is expected to boost growth of the market. For instance, in November 2019, research conducted by the Center for Allergy and Asthma Research at Stanford University and funded by AnaptysBio, Inc. found that a single dose of etokimab could have the potential to desensitize peanut-allergic participants and possibly reduce atopy-related adverse events.
• In April 2019, HypoPet announced the publication of important preclinical data for their cat allergy vaccine, HypoCatTM, which showed that HypoPet’s virus?like particle vaccine targeting the major feline allergen to which humans are allergic, successfully induced Fel d 1 binding antibodies in cats and that these antibodies neutralized the allergen.
• In October 2019, a study in the Australasian Journal of Dermatologystated that fragrances are the leading cause of allergic skin reactions in children.